TherapeuticsMD, Inc. — Director's Dealing 2011

Oct 11, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (AMHND)
CIK: 0000025743
Period of Report: 2011-10-04

Reporting Person: Milligan John C.K. IV (Director, President, Secretary, Director, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6368018	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-qualified Stock Option	$0.1018	2019-01-01	Common Stock (2052255)		Direct
Common Stock Purchase Warrant	$0.4074	2021-06-06	Common Stock (61372)		Direct

Footnotes

F1: Option vests at the rate of 6,137 shares per month over the first year from the date of issuance. Shares vested to date are 73,646. This option was assumed and re-issued pursuant to the Merger Agreement between the Company and VitaMedMD, LLC which closed on October 4, 2011.

F2: Warrant vested on issuance. This warrant was assumed and re-issued pursuant to the Merger Agreement between the Company and VitaMedMD, LLC which closed on October 4, 2011.